Top news of June: Clarifying aspirin recommendations; vocal features predict AF; and more

Healio and Cardiology Today have compiled the most-read cardiology news of June 2022.

Readers were most interested in improving the messaging surrounding aspirin; the midterm CV safety of men’s hormone therapy; promotion of hands-only CPR to increase use and improve cardiac arrest outcomes; and more.

Sperling: Messaging around aspirin could be better

The question of who should take aspirin is a complicated one and public messaging on it is sometimes confusing, a speaker said at the Heart in Diabetes CME conference. Read more

Meta-analysis: Testosterone treatment not linked to short-, medium-term CV events in men

In men with hypogonadism, there was no evidence that testosterone treatments cause short-term or medium-term CV risks, according to a meta-analysis published in The Lancet Healthy Longevity. Read more

USPSTF: No benefit of beta carotene, vitamin E, multivitamins in CVD, cancer prevention

The U.S. Preventive Services Task Force issued a recommendation statement against the use of beta carotene or vitamin E supplements for the prevention of CVD or cancer. Read more

Promotion of hands-only CPR could increase usage, improve outcomes in cardiac arrest

National CPR and AED Awareness Week, initiated by the American Heart Association, the American Red Cross and the National Safety Council and designated by Congress in 2007, is held June 1 to 7 of each year. Read more

Changes in vocal features predict AF in novel screening method

A novel screening method using vowel sounds accurately predicted atrial fibrillation in a cohort of patients referred for cardioversion, researchers reported. Read more

Burnout, uncivil behaviors create challenges in cardiology workplaces

Building civility, respect and inclusion into the cardiology workplace is essential, especially in an era where burnout is so high, a speaker said at the National Lipid Association Scientific Sessions. Read more

AHA: Vaping causes CV, respiratory adverse effects; action needed to curb teen use

Evidence suggests vaping causes adverse CV and respiratory effects, so action must be taken to reduce or prevent access to e-cigarettes to adolescents, according to an American Heart Association scientific statement. Read more

FDA designates recall of HVAD batteries as class I

The FDA has labeled Medtronic’s single-lot recall of ventricular assist device system batteries due to risk for battery failure as class I, the most serious type of recall. Read more

Gas stoves improve household air quality but may not affect gestational BP

Use of a gas stove, despite improving household air quality, did not improve gestational BP in pregnant participants in lower-income countries, and contrarily increased BP compared with solid fuel burning stoves, researchers reported. Read more

Lipid-lowering therapies underused for primary CVD prevention

In a cohort of more than 400,000 patients at high risk for CVD requiring primary prevention, less than half were taking appropriately dosed statins and less than 10% were taking nonstatin lipid-lowering therapies, researchers reported. Read more